LAB250117P2500
- 0.00
- 0.000.00%
Standard BioTools Newsroom
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Standard BioTools Inc. (NASDAQ:LAB) Not Flying Under The Radar
Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness
Express News | Standard BioTools - Alex Kim Will No Longer Serve as Co’s Chief Operating Officer, & Co Will Vacate Position of Chief Operating Officer
Express News | Standard BioTools Appoints Alex Kim as Chief Financial Officer
Press Release: Standard BioTools Appoints Alex Kim as Chief Financial Officer
Standard BioTools | 10-Q: Q3 2024 Earnings Report
Earnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17
TD Cowen Maintains Standard BioTools(LAB.US) With Buy Rating, Maintains Target Price $2.5
TD Cowen Maintains Standard BioTools(LAB.US) With Buy Rating, Cuts Target Price to $2.5
Standard BioTools Inc. (LAB) Q3 2024 Earnings Call Transcript Summary
Standard BioTools GAAP EPS of -$0.07 Beats by $0.03, Revenue of $44.96M Beats by $3.96M
Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q3 Revenue $45M
Standard BioTools | 8-K: Standard BioTools Reports Third Quarter 2024 Financial Results
Standard BioTools: Q3 Earnings Snapshot
Standard BioTools 3Q Rev $45M >LAB
Express News | Standard BioTools Inc: Qtrly Shr Loss $0.07
Express News | Standard BioTools Inc: Reiterated Its Full Year 2024 Revenue Guidance
Express News | Standard BioTools Q3 Adjusted Gross Margin 56.9%
Express News | Standard BioTools Q3 Operating Income USD -31.7 Million